Sentences with phrase «relapse after therapy»

Some studies suggest that clients who receive CT or Cognitive Behavioral Therapy (CBT) do not tend to have as much relapse after therapy is concluded.

Not exact matches

The findings, published online Nov. 13 in Science Translational Medicine, could pave the way for improvements in preventing GVHD and rejection of transplanted bone marrow and new therapies to prevent or treat a relapse of the underlying cancer after a transplant.

Dr. Rassool says that a clinical trial is planned to test whether low doses of a DNMT inhibitor, decitabine, and an investigational PARP inhibitor, talazoparib, can be safely combined and whether this therapy shows efficacy for AML patients, especially those who can not receive intensive chemotherapy, whose leukemia is resistant to treatment, or who have experienced a relapse after treatment.

Therapy of infected mice quickly ameliorated disease signs, but even after five days of treatment, some bacteria still survived in the tissues, posing a risk for relapse.

While the patient eventually relapsed and died more than a year after CAR T - cell therapy, the brain tumor never recurred.

After seeing promising results in phase 1 of the Pediatric Leukemia Adoptive Therapy (PLAT - 02) trial with 93 percent of patients with relapsed or refractory acute lymphoblastic leukemia (ALL) achieving complete initial remission, researchers at Seattle Children's are continuing their quest to improve the experimental therapy and reduce the rate of relapse, which is about 50 pTherapy (PLAT - 02) trial with 93 percent of patients with relapsed or refractory acute lymphoblastic leukemia (ALL) achieving complete initial remission, researchers at Seattle Children's are continuing their quest to improve the experimental therapy and reduce the rate of relapse, which is about 50 ptherapy and reduce the rate of relapse, which is about 50 percent.

Ninety percent of children and adults with acute lymphoblastic leukemia (ALL) who had relapsed multiple times or failed to respond to standard therapies went into remission after receiving an investigational personalized cellular therapy, CTL019, developed at the Perelman School of Medicine at the University of Pennsylvania.

«While each of these genes was independently associated with metastatic prostate cancer, they have never been studied together in the context of early detection of patients with prostate cancer that will relapse after localized therapy with curative intent, «according to the authors, led by Leigh Ellis, PhD, in the Dana - Farber Department of Oncologic Pathology.

The researchers found that a complete response to initial therapy led to longer overall survival but did not impact treatment - free intervals after relapse of the disease.

The therapy is approved by the U.S. Food and Drug Administration for relapsed or treatment - resistant Hodgkin lymphoma, and it is commonly prescribed to patients whose disease has progressed after autologous stem cell transplant, a procedure that replenishes the bone marrow with the patient's own healthy stem cells after therapy.

After analyzing the data, he and his collaborators in Berlin are convinced that the activity of Shp2 and its target genes can predict the outcome of breast cancer: The less active Shp2 is, the higher the chance for the affected women to stay relapse - free after having undergone a successful breast cancer theAfter analyzing the data, he and his collaborators in Berlin are convinced that the activity of Shp2 and its target genes can predict the outcome of breast cancer: The less active Shp2 is, the higher the chance for the affected women to stay relapse - free after having undergone a successful breast cancer theafter having undergone a successful breast cancer therapy.

Conditional survival and excess mortality after high - dose therapy with autologous stem cell transplantation for adult refractory or relapsed Hodgkin lymphoma in Norway.

• Subject is refractory to or relapsed after first - line AML therapy (with or without hematopoietic stem cell transplant (HSCT)-RRB-.

City of Hope will be the one of the first authorized centers in the nation to provide axicabtagene ciloleucel, which the U.S. Food and Drug Administration (FDA) announced today is the first approved CAR T therapy for adult patients who have not responded to or who have relapsed after at least two other kinds of treatment.

The FDA has approved the CAR T - cell therapy axicabtagene ciloleucel (Yescarta) for the treatment of large B - cell lymphomas in adults who have failed or relapsed after two or more prior treatments.

Venetoclax has durable clinical activity in patients with relapsed / refractory chronic lymphocytic leukemia whose disease progressed during or after ibrutinib therapy.

A traditional goal of salvage therapy in the refractory / relapsed population has been to transition patients to transplant, but in trials of inotuzumab and blinatumomab, there has been no clear impact on survival after censoring patients at the time of transplant.

They survive after cancer therapy and replenish the cancerous mass, leading to relapse.

Dr. Ashleigh Levison discusses relapse rates among JIA - associated uveitis patients after stopping immunomodulatory therapy.

After a median follow - up of five years, either hormone therapy plus Zometa reduced the risk of relapse by 36 percent compared with hormone therapy alone.

Relapse following successful radioactive iodine therapy is very rare but occurs in approximately 1 in 200 cats 2 - 5 years after.

A patient is declared cured from the current infection if there is no relapse of demodicosis for more than 12 months after miticidal therapy is discontinued.2

The therapeutic dotential of dietary precursor modulation by a fish - oil - supplemented diet (n - 3 fatty acids), such as eicosapentaenoic acid (C20: 5,n - 3) and docosahexaenoic acid (C22: 6,n - 3) in the therapy of ulcerative colitis has been shown to result in a 35 % to 50 % decrease in neutrophil production of LTB4.28 Significant improvement in symptoms and histologic appearance of the rectal mucosa has been observed in several small series of patients with Crohn's disease and ulcerative colitis given fish oil at 3 to 4 g daily for 2 to 6 months in uncontrolled studies.29 However, a larger, randomized, double - blind trial comprising 96 patients with ulcerative colitis failed to reveal any benefit in remission maintenance or treatment of relapse on 4.5 g of eicosapentaenoic acid daily, despite a significant reduction in LTB4 synthesis by blood peripheral polymorphonuclear cells.30 It should be emphasized, however, that the anti-inflammatory actions of the fish oils, in addition to inhibition of LTB4, include suppression of IL - 1 and platelet activating factor synthesis and scavenging of free oxygen radicals.30 The impact of increased lipid peroxidation after fish oil supplementation should be considered when altering the n - 6: n - 3 fatty acid ratio.31 Antioxidant supplementation may be able to counteract the potentially adverse effects of n - 3 fatty acids.

This difference resulted in a statistically significant improvement in survival after salvage therapy for relapsed Group 2 dogs receiving salvage therapy compared to relapsed Group 3 dogs who received salvage therapy (p = 0.038)(Fig. 3).

Continuation - phase cognitive therapy and fluoxetine are effective in reducing the risk of relapse / recurrence in major depression after incomplete remission

Arch Gen Psychiatry1998Sep; 55:816 — 20OpenUrlCrossRefPubMedWeb of Science Question In patients who have recurrent depression after successful antidepressant treatment, is cognitive behavioural therapy (CBT) effective for reducing residual symptoms and relapse rates?

In patients with recurrent depression after successful drug treatment, cognitive behavioural therapy and tapered doses of antidepressants led to fewer residual symptoms and relapses than did clinical management and tapered doses of antidepressants.

Talk about stress One study discovered that the spillover of external stress into the relationship was the single biggest reason why couples relapsed two years after marital therapy.

According to Dr. Gottman's close friend and colleague, UW's Dr. Neil Jacobson, one of the key reasons for couples» relapse after problem - solving in marital therapy is «discord caused by stress from other areas of their lives.»

Duration of relapse prevention after cognitive therapy in residual depression: follow - up of controlled trial.

Personalized treatment plans are developed for each client after a complete evaluation is completed combined with Medically Assisted Detoxification, Cognitive Behavior Therapy, 12 Step Therapy and life skills help our clients work through problems and prevent relapse.

This is a critical reason for the alarmingly high relapse rate after seemingly successful therapy.

Research indicates that the skills individuals learn through relapse prevention therapy remain after the completion of treatment.

Where other couples therapies have a success rate of only about 30 % and couples relapse after a year, EFT is a proven effective treatment for distressed couples and families.